Elite Pharmaceuticals, Inc. (ELTP) Revenue 2017–2026
Elite Pharmaceuticals, Inc. (ELTP) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$148.9MFY2026 · since FY2017: $9.6M → $148.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $148.9M | +77.1% |
| FY2025 | $84.0M | +48.4% |
| FY2024 | $56.6M | +65.8% |
| FY2023 | $34.2M | +5.9% |
| FY2022 | $32.3M | +27.1% |
| FY2021 | $25.4M | +41.0% |
| FY2020 | $18.0M | +137.8% |
| FY2019 | $7.6M | +1.5% |
| FY2018 | $7.5M | -22.6% |
| FY2017 | $9.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice